XBiotech Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +247.0% | -58.2% | -78.2% | -92.5% | -100.0% | – | |
| – | +5.3% | -0.1% | +112.6% | +63.9% | -3.0% | +1,363.3% | -83.2% | -88.8% | +167.9% | +0.1% | -3.4% | |
| – | – | – | – | – | – | – | +33.1% | -73.3% | -151.9% | – | – | |
| – | +118.5% | +35.7% | -37.8% | -40.5% | +53.2% | -60.5% | +196.7% | +11.6% | +4.1% | +14.9% | +25.5% | |
| – | -16.8% | +65.8% | -25.7% | -31.0% | +35.6% | +154.8% | -48.4% | -32.8% | -26.1% | +1.1% | +76.0% | |
| – | +74.3% | +41.4% | -37.4% | -43.0% | +55.6% | -4.0% | +35.8% | +0.5% | -0.9% | +13.2% | +27.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -98.8% | -87.8% | -17.0% | -100.0% | – | -89.1% | |
| – | – | – | – | – | – | -101.8% | – | – | – | – | – | |
| – | – | – | – | – | – | -103.2% | – | – | – | -113.1% | – | |
| – | – | – | – | – | – | -101.7% | – | – | – | – | – | |
| – | – | – | – | – | – | -102.2% | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.